BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xie Y, Zhu Y, Zhou H, Lu ZF, Yang Z, Shu X, Guo XB, Fan HZ, Tang JH, Zeng XP, Wen JB, Li XQ, He XX, Ma JH, Liu DS, Huang CB, Xu NJ, Wang NR, Lu NH. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection. World J Gastroenterol 2014; 20(32): 11415-11421 [PMID: 25170230 DOI: 10.3748/wjg.v20.i32.11415]
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11415.htm
Number Citing Articles
1
Youn I Choi, Sang-Ho Jeong, Jun-Won Chung, Dong Kyun Park, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Seol So, Jeong Hoon Lee, Jin-Young Jeong, Sun-Mi Lee. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in KoreaCanadian Journal of Infectious Diseases and Medical Microbiology 2019; 2019: 1 doi: 10.1155/2019/9351801
2
Yi Hu, Yin Zhu, Nong-Hua Lu. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic ResistanceFrontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00168
3
Yi Hu, Yin Zhu, Nong-hua Lu. Primary Antibiotic Resistance of Helicobacter pylori in ChinaDigestive Diseases and Sciences 2017; 62(5): 1146 doi: 10.1007/s10620-017-4536-8
4
Chao-ran Ji, Jing Liu, Yue-yue Li, Chuan-guo Guo, Jun-yan Qu, Yan Zhang, Xiuli Zuo. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysisBMJ Open 2020; 10(10): e037375 doi: 10.1136/bmjopen-2020-037375
5
You-hua Wang, Zhi-fa Lv, Yao Zhong, Dong-sheng Liu, Shu-ping Chen, Yong Xie. The internalization ofHelicobacter pyloriplays a role in the failure ofH. pylorieradicationHelicobacter 2017; 22(1): e12324 doi: 10.1111/hel.12324
6
Muhammad Miftahussurur, Hafeza Aftab, Pradeep Krishna Shrestha, Rabi Prakash Sharma, Phawinee Subsomwong, Langgeng Agung Waskito, Dalla Doohan, Kartika Afrida Fauzia, Yoshio Yamaoka. Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibioticsAntimicrobial Resistance & Infection Control 2019; 8(1) doi: 10.1186/s13756-019-0482-x
7
Jie Pan, Zhengchao Shi, Dingsai Lin, Ningmin Yang, Fei Meng, Lang Lin, Zhencheng Jin, Qingjie Zhou, Jiansheng Wu, Jianzhong Zhang, Youming Li. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trialFrontiers of Medicine 2020; 14(1): 43 doi: 10.1007/s11684-019-0706-8
8
Chongshan Dai, Lei Lei, Bin Li, Yang Lin, Xilong Xiao, Shusheng Tang. Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcuminToxicology Mechanisms and Methods 2017; 27(3): 165 doi: 10.1080/15376516.2016.1273424
9
Yong Xie, Zhenyu Zhang, Junbo Hong, Wenzhong Liu, Hong Lu, Yiqi Du, Weihong Wang, Jianming Xu, Xuehong Wang, Lijuan Huo, Guiying Zhang, Chunhui Lan, Xiaoyan Li, Yanqing Li, Hong Wang, Guoxin Zhang, Yin Zhu, Xu Shu, Ye Chen, Jiangbin Wang, Nonghua Lu. Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China Helicobacter 2018; 23(5): e12496 doi: 10.1111/hel.12496
10
Liya Zhuge, Youhua Wang, Shuang Wu, Ru‐Lin Zhao, Zhen Li, Yong Xie. Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta‐analysis Helicobacter 2018; 23(2): e12468 doi: 10.1111/hel.12468
11
Chen Qiao, Yueyue Li, Jing Liu, Chaoran Ji, Junyan Qu, Junnan Hu, Rui Ji, Meng Wan, Boshen Lin, Minjuan Lin, Qingqing Qi, Xiuli Zuo, Yanqing Li. Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area Journal of Gastroenterology and Hepatology 2021; 36(9): 2383 doi: 10.1111/jgh.15468
12
Luyi Chen, Jiamin He, Lan Wang, Qiwei Ge, Hua Chu, Yujia Chen, Xiaoli Chen, Yanqin Long, Yanyong Deng, Huiqin He, Aiqing Li, Shujie Chen. Efficacies of different proton pump inhibitor-based 14-day bismuth–furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trialClinical and Experimental Medicine 2018; 18(4): 569 doi: 10.1007/s10238-018-0510-9
13
Ya-Wen Zhang, Wei-Ling Hu, Yuan Cai, Wen-Fang Zheng, Qin Du, John J Kim, John Y Kao, Ning Dai, Jian-Min Si. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for <i>Helicobacter pylori</i> infection and predictors of failed eradicationWorld Journal of Gastroenterology 2018; 24(40): 4596-4605 doi: 10.3748/wjg.v24.i40.4596
14
Chongshan Dai, Daowen Li, Lijing Gong, Xilong Xiao, Shusheng Tang. Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial PathwayMolecules 2016; 21(8): 1061 doi: 10.3390/molecules21081061
15
Conghua Song, Xing Qian, Yin Zhu, Xu Shu, Yanping Song, Zhijuan Xiong, Jianfang Ye, Tao Yu, Ling Ding, Hui Wang, Nonghua Lu, Yong Xie. Effectiveness and safety of furazolidone‐containing quadruple regimens in patients with Helicobacter pylori infection in real‐world practice Helicobacter 2019; : e12591 doi: 10.1111/hel.12591
16
Tian Geng, Zhong-Su Yu, Xi-Xi Zhou, Bo Liu, Hui-Hua Zhang, Zhong-Yue Li. Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, ChinaEuropean Journal of Pediatrics 2022;  doi: 10.1007/s00431-022-04456-1
17
Yong Xie, Zhenhua Zhu, Jiangbin Wang, Lingxia Zhang, Zhenyu Zhang, Hong Lu, Zhirong Zeng, Shiyao Chen, Dongsheng Liu, Nonghua Lv. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in ChinaAntimicrobial Agents and Chemotherapy 2018; 62(9) doi: 10.1128/AAC.00432-18
18
Wen Zhong Liu, Yong Xie, Hong Lu, Hong Cheng, Zhi Rong Zeng, Li Ya Zhou, Ye Chen, Jiang Bin Wang, Yi Qi Du, Nong Hua Lu. Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfectionHelicobacter 2018; 23(2): e12475 doi: 10.1111/hel.12475
19
Dong-Min Yi, Tao-Tao Yang, Shuai-Heng Chao, Ya-Xin Li, Ying-Lei Zhou, Hai-Hui Zhang, Ling Lan, Yu-Wei Zhang, Xue-Mei Wang, Yan-Rui Zhang, Jian Li, Song-Ze Ding. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label studyMedicine 2019; 98(6): e14408 doi: 10.1097/MD.0000000000014408
20
Shumei Ma, Zhao Jin, Yi Liu, Lin Liu, Hao Feng, Ping Li, Zhujun Tian, Minghua Ren, Xiaodong Liu, Ana Lloret. Furazolidone Increases Survival of Mice Exposed to Lethal Total Body Irradiation through the Antiapoptosis and Antiautophagy MechanismOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/6610726
21
Anthony O'Connor, Javier P. Gisbert, Colm O'Morain, Spiros Ladas. Treatment ofHelicobacter pyloriInfection 2015Helicobacter 2015; 20: 54 doi: 10.1111/hel.12258
22
Huan Li, Xiu-Juan Xia, Lin-Fang Zhang, Jing-Shu Chi, Peng Liu, Hao Wu, Xiao-Ran Xie, De-Lin Tian, Kai-Xiao Kun, Ren-jie Gong, Xiao-Ming Liu, Can-Xia Xu. Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized studyEuropean Journal of Gastroenterology & Hepatology 2021; 32(2): 194 doi: 10.1097/MEG.0000000000001896
23
Jian Fang Ye, Jun Bo Hong, Yin Zhu, Yong Xie, Xu Shu, Ling Yu Luo, Chuan Xie, Zhen Hua Zhu, Nong Hua Lu. Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradicationJournal of Digestive Diseases 2017; 18(12): 704 doi: 10.1111/1751-2980.12559
24
Sandra Martínez-Puchol, Cláudia Gomes, Maria J. Pons, Lidia Ruiz-Roldán, Alba Torrents de la Peña, Theresa J. Ochoa, Joaquim Ruiz. Development and analysis of furazolidone-resistantEscherichia colimutantsAPMIS 2015; 123(8): 676 doi: 10.1111/apm.12401
25
Junxian Wang, Yuping Cao, Wei He, Xiaoping Li. Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pyloriMedicine 2021; 100(51): e28323 doi: 10.1097/MD.0000000000028323